Concepedia

Peter R. Twentyman

PR

Statistics

Publications

30

Citations

1.3K

H-Index

20

Active since

1978

Affiliations

MRC Cancer Unit(Current)

Medical Research Council

Stanford University

University of Cambridge

Bridge University

Peter R. Twentyman is an author at MRC Cancer Unit specializing in medicine, oncology, and chemotherapy.

Publications per year

1978–1997

30

Publications

30

Resistance modification by PSC-833, a novel non-immunosuppressive cyclosporin A

Peter R. Twentyman, Norman M. Bleehen · European Journal of Cancer and Clinical Oncology · 1991 · 211 citations

Medicine, Pharmacology, Pharmacotherapy +9

Chemosensitivity testing of fresh leukaemia cells using the MTT colorimetric assay

Peter R. Twentyman, Norma E. Fox, J. K. H. Rees · British Journal of Haematology · 1989 · 128 citations

Medicine, Oncology, Pharmacology +14

Establishment and characterization of cisplatin‐resistant sublines of human lung cancer cell lines

Weon‐Seon Hong, Nagahiro Saijo, Y Sasaki et al. · International Journal of Cancer · 1988 · 84 citations

Medicine, Oncology, Pharmacology +15

Resistance to Antineoplastic Drugs

Peter R. Twentyman · British Journal of Cancer · 1990 · 81 citations · Full text

Medicine, Oncology, Pharmacology +12

Improved cellular accumulation is characteristic of anthracyclines which retain high activity in multidrug resistant cell lines, alone or in combination with verapamil or cyclosporin A

Helen M. Coley, Peter R. Twentyman, Paul Workman · Biochemical Pharmacology · 1989 · 62 citations

Medicine, Cell Biology, Pharmacology +14

1–5 of 30